Justin Romans

Account Executive at ZOLL TherOx | Interventional Cardiology | Heart Failure | Capital Equipment

Role: Account Executive, Western Us at Zoll Therox
Location: San Diego, CA, US
LinkedIn followers: 500 followers

Sales & Business DevelopmentView LinkedIn profile

About Justin Romans

An accomplished and award winning medical device sales professional with a comprehensive…

Experience

Account Executive, Western Us
Zoll Therox
Jun 2024 — Present · San Diego, CA, US

Education

San Diego State University
Bachelor of Science - BS

Skills

Medical Devices
Sales Management
Contract Negotiation
Strategic Planning
Succession Planning
Direct Sales
New Business Development
Operating Room
Sales
Sales Operations
Sales Process
Selling
Capital Equipment
Cold Calling
Disposables
Market Development
Surgeons
Sales Force Development
Orthopedic
Selling Skills
Vascular
Medical Sales
Hospitals
Account Management
Leadership
Management
Solution Selling
Sales Presentations
Orthopedics
Product Launch
Working with Surgeons
Business Development

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
j••••••@zoll.com
Personal email
•••••@•••••.com
Direct dial
+19•••••••40

Unlock verified contacts

Free to start · No credit card required

Current company

Zoll Therox

Medical Equipment Manufacturing · 33 employees · Founded 1995 · San Jose, California, United States

TherOx is a part of ZOLL Medical Corporation. Based in San Jose, California, TherOx is focused on improving the treatment of heart attacks (acute myocardial infarction, or AMI). The company is commercializing SuperSaturated Oxygen (SSO2) Therapy for the sizeable AMI patient population to save hearts, improving and ultimately saving lives. SSO2 Therapy is based on the known benefits of hyperbaric oxygen treatment in improving the body’s ability to heal. SSO2 Therapy infuses superoxygenated blood to improve microvascular flow after successful percutaneous coronary intervention (PCI) and has been shown to save heart muscle by reducing infarct size. Immediately after the coronary artery has been opened by PCI, SSO2 Therapy delivers a one-time, 60-minute infusion of the patient’s superoxygenated blood to the targeted ischemic area of the heart through a small catheter. The superoxygenated blood helps reduce capillary swelling to restore blood flow to surrounding tissue and decrease infarct size. SSO2 Therapy is aligned with current guidelines for interventional cardiology procedures. SSO2 Therapy is indicated for the preparation and delivery of supersaturated oxygen to targeted ischemic regions perfused by the patient’s left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within six hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.

therox.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Justin Romans

Experience

Account Executive, Western Us

Education

San Diego State University

Skills

Find verified contacts for anyone on LinkedIn